ArticleJournal of translational medicine2025

Comment on "SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis" critical considerations on biomarker validation and Supraphysiological drug concentrations.

Jie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.